Arcus Biosciences RCUS
NYSE RCUS
$24.46 -0.76 (-3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcus Biosciences (RCUS) Non Operating Investment Income (2018 - 2020)

Updated

Arcus Biosciences' Non Operating Investment Income came in at $613,000 for FY2020.

Analysis

Arcus Biosciences (RCUS) Non Operating Investment Income (2018 - 2020) Analysis & Trends

  • Per Business Quant, earlier years put Non Operating Investment Income at $1.23 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Arcus Biosciences 3.11 Bn -229.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 131,000.00
Mar 31, 2020 482,000.00
Jun 30, 2018 1.23 Mn
API Access

Arcus Biosciences Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=RCUS&period=max&api_key=YOUR_API_KEY